What is Novastep?
Novastep International is a prominent player in the medical device industry, specializing in the design, development, and commercialization of advanced solutions for foot and ankle surgery. Their innovative product portfolio includes the PECA MIS Bunion Correction and AIRLOCK Plating System, engineered to enhance surgical outcomes and patient recovery. The company primarily serves healthcare professionals and institutions engaged in orthopedic surgery, with a particular emphasis on foot and ankle procedures. Novastep is dedicated to introducing disruptive technologies that improve surgical efficiency and patient well-being.
How much funding has Novastep raised?
Novastep has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
What's next for Novastep?
The substantial backing and recent strategic investment signal Novastep's readiness for accelerated expansion and market leadership. As a company in a large-scale, late-stage funding phase, Novastep is poised to further refine its product development pipeline, scale its commercial operations, and potentially explore new therapeutic areas within orthopedic surgery. This capital infusion is expected to fuel innovation, strengthen its global presence, and solidify its competitive advantage in providing cutting-edge solutions for foot and ankle pathologies.
See full Novastep company page
